Interferon-β treatment for multiple sclerosis - PMC - PubMed …
Interferon-β, approved for use in 1993, was the first treatment to modify the course and prognosis of the disease and remains a mainstay of MS treatment. Numerous large-scale clinical trials in early, active patient populations have established the clinical efficacy of interferon-β in reducing relapses and delaying disability progression.
Interferon Beta Drugs for Multiple Sclerosis - WebMD
2024年3月6日 · 4 min read. Your body makes interferons naturally. Three forms -- alpha, beta, and gamma -- control the activity of your immune system. But doctors also can use a man-made version of these forms to...
Interferons in the Treatment of Multiple Sclerosis: A Clinical
Interferon beta (IFNβ) was the first disease-modifying therapy available to treat multiple sclerosis (MS), providing patients with a treatment that resulted in reduced relapse rates and delays in the onset of disability.
Interferons and Multiple Sclerosis: Lessons from 25 Years of …
Since 1981, clinical and real-world observational studies have demonstrated the effectiveness of interferon therapies in reducing relapse rate, disability worsening/progression, and the number of new or newly enlarging lesions in patients with multiple sclerosis (MS).
Interferon - StatPearls - NCBI Bookshelf
2023年7月10日 · Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin’s lymphoma, and autoimmune diseases such as multiple sclerosis. This activity outlines the different types of interferons, namely interferon alpha, beta, …
Interferons in the Treatment of Multiple Sclerosis
2019年10月30日 · Interferon beta (IFNβ) was the first disease-modifying therapy available to treat multiple sclerosis (MS), providing patients with a treatment that resulted in reduced relapse rates and delays in the onset of disability.
Interferon beta-1b (subcutaneous route) - Mayo Clinic
2024年2月1日 · Interferon beta-1b injection is used to treat the relapsing-remitting forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Interferon beta-1a (intramuscular route, subcutaneous route)
2024年1月31日 · Interferon beta-1a injection is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Rebif (Interferon Beta-1a) in MS | Uses, Side Effects, and More
2022年5月13日 · Rebif (interferon beta-1a) is a widely approved injectable medication used for people with relapsing forms of multiple sclerosis (MS) to slow the accumulation of disability …
Interferon Treatment of Multiple Sclerosis - PMC - National …
2011年12月12日 · The U.S. Food and Drug Administration (FDA) has approved three forms of interferon beta for treating MS. Beta interferon (IFN-B) has multiple effects on the immune system, including an increase in suppressor cell activity and stopping antigens that …